Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lysosome is a specialized membrane-bound organelle that serves as the primary degradative compartment of the cell, housing over 60 acidic hydrolases (Settembre et al., 2013, Nature Reviews Molecular Cell Biology). The lysosomal membrane is critical for maintaining an acidic luminal pH (4.5–5.0) through the action of V-ATPases and for regulating the efflux of catabolic products via specific transporters (Appelqvist et al., 2013, Journal of Molecular Cell Biology). Beyond waste disposal, the lysosome acts as a metabolic signaling hub, integrating nutrient sensing through the mTORC1 pathway (Wang et al., 2018, Trends in Cell Biology). Dysregulation of lysosomal function or membrane integrity is a hallmark of lysosomal storage diseases (LSDs), such as Gaucher and Pompe disease, and is increasingly implicated in neurodegenerative disorders like Parkinson's and Alzheimer's (Platt et al., 2018, Nature). Pharmacological interventions include enzyme replacement therapies, substrate reduction agents, and lysosomotropic drugs like hydroxychloroquine that alter luminal pH (Boya & Kroemer, 2008, Nature Reviews Drug Discovery). In oncology, the induction of lysosomal membrane permeabilization (LMP) is explored as a mechanism to bypass apoptosis resistance and trigger cathepsin-mediated cell death (Boya & Kroemer, 2008, Nature Reviews Drug Discovery).
Modulation of lysosomal pH, enzyme replacement therapy (ERT), substrate reduction therapy (SRT), pharmacological chaperoning, or induction of lysosomal membrane permeabilization (LMP).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosomal membrane and function.